---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-063235"
form_type: "8-K"
ticker: "RVRC"
cik: "0001839140"
company_name: "Revium Rx."
filed_at: "2026-06-01T13:58:55+00:00"
generated_at: "2026-06-01T14:00:16.805160+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Revium Rx CFO Arie Gordashnikov resigns; Igor Bluvstein appointed effective May 27, 2026

## Summary
- Arie Gordashnikov resigned as CFO effective May 27, 2026, with no disagreement with the company.
- Igor Bluvstein appointed CFO same date; previously CFO at Argent BioPharma and G Medical Innovations.
- Bluvstein receives monthly retainer of NIS17,000 plus VAT.
- Bluvstein has over 17 years of financial leadership experience and is a CPA.

## SEC filing metadata
- accession: 0001213900-26-063235
- form_type: 8-K
- ticker: RVRC
- cik: 0001839140
- company_name: Revium Rx.
- filed_at: 2026-06-01T13:58:55+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839140/000121390026063235/0001213900-26-063235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839140/000121390026063235/ea0292932-8k_revium.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-063235
- JSON: https://secwatch.observer/filing/0001213900-26-063235.json
- Plain text: https://secwatch.observer/filing/0001213900-26-063235.txt

## Source-grounded claims
- claim_id: 613425899b
  claim: Igor Bluvstein was appointed as Chief Financial Officer at Revium Rx..
  evidence_excerpt: On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839140/000121390026063235/0001213900-26-063235-index.htm
- claim_id: 70b90fcd8f
  claim: Arie Gordashnikov resigned as Chief Financial Officer at Revium Rx..
  evidence_excerpt: On May 27, 2026, Mr. Arie Gordashnikov resigned from his position as Chief Financial Officer of Revium Rx.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839140/000121390026063235/0001213900-26-063235-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.